Nanotechnology-Based Strategies for Overcoming Clinical Limitations of PROTACs in Cancer Therapy

Q: What type of study is this?

This is a Experimental Study study.

Hanhee Cho; Jinseong Kim; Ho-Yeon Lee; Hyein Kang; Kwangmeyung Kim

doi:10.1039/d5tb01162k

January 1, 2025Journal of Materials Chemistry B

Nanotechnology-Based Strategies for Overcoming Clinical Limitations of PROTACs in Cancer Therapy

View Full Paper

Ask AI

Bookmark

Share

Key Points

Nanotechnology-based interventions show promise in enhancing the therapeutic potential of PROTACs in oncology.
Clinical studies indicate that although PROTACs are effective, they may present significant adverse effects that need addressing.
Nanotechnology provides a promising approach to overcome the limitations of PROTACs while ensuring targeted degradation of cancer proteins.
This research suggests that integrating nanotechnology with PROTACs may augment their applications in cancer treatments.

Implication

This analysis highlights nanotechnology's role in improving PROTAC safety and effectiveness in cancer therapy.

Abstract

Proteolysis-targeting chimeras (PROTACs) have emerged as a promising next-generation therapeutic modality by enabling complete degradation of target proteins rather than transient inhibition. However, increasing clinical studies have reported adverse effects...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cho et al. (2025) studied this question.

synapsesocial.com/papers/68d6d8768b2b6861e4c3e7b9 https://doi.org/10.1039/d5tb01162k

View Full Paper

Ask AI

Bookmark

Share

Nanotechnology-Based Strategies for Overcoming Clinical Limitations of PROTACs in Cancer Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Nanotechnology-Based Strategies for Overcoming Clinical Limitations of PROTACs in Cancer Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading